Good Life Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-710
Closed -$309K 513
2025
Q1
$309K Buy
710
+91
+15% +$36.5K 0.02% 380
2024
Q4
$228K Sell
619
-6
-1% -$2.51K 0.02% 428
2024
Q3
$325K Buy
625
+63
+11% +$33.7K 0.02% 448
2024
Q2
$305K Buy
562
+21
+4% +$11.1K 0.03% 356
2024
Q1
$281K Hold
541
0.02% 360
2023
Q4
$256K Sell
541
-60
-10% -$27.7K 0.03% 361
2023
Q3
$262K Buy
601
+5
+0.8% +$2.27K 0.03% 341
2023
Q2
$265K Sell
596
-177
-23% -$81.7K 0.03% 332
2023
Q1
$355K Sell
773
-40
-5% -$19K 0.05% 268
2022
Q4
$418K Buy
813
+2
+0.2% +$1.01K 0.06% 220
2022
Q3
$368K Sell
811
-4
-0.5% -$1.91K 0.05% 225
2022
Q2
$393K Buy
815
+157
+24% +$77.7K 0.05% 222
2022
Q1
$323K Sell
658
-46
-7% -$21K 0.04% 274
2021
Q4
$326K Buy
704
+31
+5% +$13K 0.04% 275
2021
Q3
$251K Sell
673
-166
-20% -$63.1K 0.03% 299
2021
Q2
$320K Sell
839
-43
-5% -$16.4K 0.06% 218
2021
Q1
$316K Buy
+882
New +$284K 0.06% 215

Other funds holding ELV

Good Life Advisors's ELV Position: Q2 2025 in Review

Good Life Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 710 shares — an estimated $309K sold.

Good Life Advisors first reported a position in ELV in Q1 2021 and held it in 17 quarters. The position peaked at $418K in Q4 2022. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Good Life Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Good Life Advisors sold 710 Elevance Health shares in Q2 2025, an estimated $309K.
  • Good Life Advisors first reported a position in Elevance Health in Q1 2021 and held it in 17 quarters.
  • Good Life Advisors's Elevance Health position peaked at $418K in Q4 2022.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.